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Abstract
Persons with Multiple Sclerosis (PwMS) commonly experience cognitive fatigue (CF), defined
as a decrease in cognitive performance over a sustained activity and measured objectively or
subjectively. In the present research, we evaluated the extent to which depression, anxiety,
information processing speed, sleep quality, and disease disability predict subjective and
objective CF, in a sample of 55 PwMS (37 females, M = 44.23 years of age). Although no
statistically significant predictors of objective CF were demonstrated, all variables predicted
subjective CF, R2adj = .384 [F (6, 40) = 5.783, p = .0002]. In particular, depression and
information processing speed were found to be significant predictors of subjective CF when
controlling for anxiety, sleep quality, and disease disability. Findings are discussed in the context
of treating subjective CF through treatment of these affective and cognitive factors (e.g., through
psychotherapy).

Keywords: Multiple Sclerosis, Cognitive Fatigue, Depression, Anxiety, Sleep Quality, Disease
Severity, Information Processing Speed
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Lay Abstract
Multiple Sclerosis (MS) is an autoimmune disorder that causes physical and cognitive
impairments. Among them, is cognitive fatigue (CF) which is objectively defined as a decrease
in cognitive performance over a sustained cognitive activity. CF can be measured objectively, by
measuring performance during a cognitive task, or subjectively, in which persons with MS
(PwMS) report the level of CF they experience on average. In the current research, we evaluated
the extent to which depression, anxiety, information processing speed, sleep quality, and disease
disability predict subjective and objective CF, in a sample of 55 PwMS (37 females, M = 44.23
years of age). While there were no significant predictors of objective CF, all variables predicted
subjective CF, R2adj = .384 [F (6, 40) = 5.783, p = .0002]. In particular, depression and
information processing speed were found to be significant predictors of subjective CF when
anxiety, sleep quality, and disease disability were controlled for. Findings are discussed in the
context of treating subjective CF through treatment of these affective and cognitive factors (e.g.,
through psychotherapy).
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Chapter 1
1.1 Multiple Sclerosis Overview
Multiple Sclerosis (MS) is an autoimmune disease caused by inflammation within the
central nervous system that results in damage to the myelin sheath (demyelination). This is the
primary determinant of the clinical symptoms (neurological deficits) of MS. As myelin is
affected in different patterns for each individual, clinical symptoms are highly variable, meaning
that the presentation of symptoms within the population of Persons with Multiple Sclerosis
(PwMS) is highly heterogeneous (van Noort, 1996). Common clinical symptoms include: muscle
weakness, spasticity, tremors, bladder dysfunction, speed and vision impairments, vertigo, and
ataxia (National Institutes of Health, 2019).
Approximately 85% of PwMS (Multiple Sclerosis International Federation, 2013), will
initially present with Relapsing Remitting MS, which is characterized by intervals of clinical
symptoms (relapse) and intervals of partial recovery (remit) (van Noort, 1996). As many as 80%
of PwMS diagnosed with Relapsing Remitting MS (Chiaravalloti & DeLuca, 2008), will then
progress into the Secondary Progressive stage, characterized as a gradual worsening of disability
with no interval of recovery. Some PwMS will, however, initially present in the progressive
stage, and are considered to have Primary Progressive MS. Individuals with this form of MS will
not have any intervals of recovery and will show a gradual increase in disability. The rate at
which the disease progresses is variable from individual to individual: it can be slow and gradual,
taking decades for the symptoms to increase, or it can be rapid, with disability increasing in a
matter of months (van Noort, 1996).
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The heterogeneity of MS is such that there is not yet a definitive etiology, but rather
evidence of multiple risk factors including genetics, social, and environmental factors (Beck,
Metz, Svenson, & Patten, 2005; van Noort, 1996).
1.1.1

Prevalence of MS
With an onset between 20 and 40 years old, MS is the most common neurological disease

(Beiske et al., 2008; Chylova et al., 2009). It affects individuals in the midst of their developing
careers, families, and relationships (Paty, Noseworthy, & Ebers, 1998). In 2013, the Multiple
Sclerosis International Federation updated their 2008 research investigating the incidence and
prevalence of MS worldwide. The number of individuals diagnosed with MS worldwide
increased to 2.3 million in 2013 from 2.1 million reported in 2008. MS has been shown to affect
twice as many women as it does men worldwide, with a ratio of 2.6:1 in the Americas and 3:1 in
Asia. The highest prevalence rates of MS are in Europe and Canada (Multiple Sclerosis
International Federation, 2013). The most detailed research of prevalence rates of MS in Canada
was conducted by Beck et al. (2005). This study investigated the overall prevalence of MS in
Canada, as well as the differences between five regions of Canada: British Columbia, the
Prairies, Ontario, Québec, and Atlantic Canada. The overall prevalence in 2005 was 240 per
100,000 people. It is likely that this number has increased since the study was conducted, as
worldwide prevalence has increased since then, but this research remains relevant as it identified
the prevalence rates in the five main regions of Canada. The highest prevalence was in Atlantic
Canada, with 350 per 100,000 people, while the lowest prevalence was in Québec with 180 per
100,000 people. Despite these demonstrated regional differences, no environmental risk factors
were identified – Atlantic Canada and the Prairies were the two highest prevalence rates and do
not share many environmental similarities (Beck et al., 2005).
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1.1.2

Symptoms of MS
The most common complaint of PwMS is fatigue, with approximately 95% of PwMS

reporting fatigue (Learmonth et al., 2013; Penner et al., 2015). Fatigue is defined as mental or
physical exhaustion, and lack of energy that has negative effects on an individual’s quality of
life. It is sometimes termed the “hidden symptom”, as it is a symptom that is not always
immediately apparent to family members or caregivers—and also because it is a symptom that an
individual will experience subjectively (Golan et al., 2018; Penner et al., 2015).
As listed above, the clinical symptoms of MS range from bladder dysfunction to vision and
speech impairment (National Institutes of Health, 2019). Clinical severity or disability due to
disease (disease disability) may be quantified in a variety of ways, but the most commonly used
measurement tool is the Expanded Disability Status Scale (EDSS; Kurtzke, 1983). The EDSS
measures seven areas of concern for PwMS: pyramidal, cerebellar, brainstem, sensory,
bowel/bladder, visual, and cerebral. Each aspect of the scale contributes to an overall score of
disability that ranges from zero (no disability), to ten (death). Scores from 0 to 4.0 are
ambulatory, and are characterized by the ability to walk without assistance (from another person,
or an aid), scores 4.5 to 7.0 are characterized as impaired walking, and 7.5 to 9.5, which is
described as inability to walk. Some of the scales are more basic, such as bowel/bladder and
vision, while others are less intuitive, such as the cerebral scale, which measures difficulties with
memory and thinking. The pyramidal scale measures muscle weakness, the cerebellar scale
assesses ataxia, loss of balance, coordination, and tremors. The brainstem scale evaluates
problems with speech and swallowing, while the sensory scale measures numbness and loss of
sensation.
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While there are many documented physical symptoms, PwMS also experience cognitive
impairment (CI), which can impact their lives even before a confirmed diagnosis of MS (Brissart
et al., 2013).
1.1.2.1

Cognitive Impairment in MS
CI affects between 40 to 65% of PwMS (Malivoire, Hare, & Hart, 2018; Morrow,

Rosehart, & Pantazopoulos, 2016), and can occur in all stages of MS (Kinsinger, Lattie, & Mohr,
2010; Rogers & Panegyres, 2007). Typically, later stages will experience the most severe
impairments (Brissart et al., 2013; Rogers & Panegyres, 2007); however, CI has been diagnosed
during the earliest stages of the disease (Brissart et al., 2013; DiGiuseppe, Blair, & Morrow,
2018). CI describes deficiencies in memory (working, episodic, and long-term), verbal fluency,
learning, attention, executive function, and most commonly, information processing speed (Blair
et al., 2016; Brissart et al., 2013; Kinsinger et al., 2010; Malivoire et al., 2018; Morrow et al.,
2016; Rogers & Panegyres, 2007). This suggests that PwMS experiencing CI will have
difficulties making decisions, thinking clearly, remembering, and processing information in a
timely manner. As such, CI is associated with decreased Quality of Life (QoL), vocational
disability, social impairment, and psychopathology, particularly depression and anxiety
(Benedict et al., 2005; Kinsinger et al., 2010; Malivoire et al., 2018; Morrow et al., 2016; Rogers
& Panegyres, 2007). For individuals that experience CI, it can be very difficult to interact with
others and carry on a vocation. Oftentimes, CI will be comorbid with mood disorders, such as
depression and anxiety (Gill, Santo, Blair, & Morrow, 2019; Kinsinger et al., 2010; Malivoire et
al., 2018), perhaps resulting in further negative effects on QoL, vocation, and socialization (Gill
et al., 2019). However, it has been demonstrated that improving psychological symptoms has
lessened perceived CI (Kinsinger et al., 2010).
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In the literature, CI is measured by performance on cognitive testing (objective) and by
self-report questionnaires (perceived or subjective). While results on both measurement methods
yield evidence of CI and both were associated with depression, objective measures were not
affected by treatment (therapy), while subjective measures were improved. Meaning that PwMS
reported less impairment following treatment, but performed the same as pre-treatment
(Kinsinger et al., 2010). As such, there are no standardized treatments available for CI in PwMS.
1.1.3

Psychosocial Impact of MS
While mood disorders are not considered to be a part of the natural progression of MS,

mood disorders are quite common among PwMS, particularly depression (Beiske et al., 2008)
and anxiety (Lester, Stepleman, & Hughes, 2007). Depression and anxiety are more prevalent in
the MS population than other neurological disorders (Viner et al., 2014), and are three times
more prevalent than in the non-MS population (Beiske et al., 2008; Viner et al., 2014).
Depression among PwMS has been suggested to have a lifetime prevalence of approximately
50%, meaning that half of PwMS will experience depression at some point in their lifetime
(Feinstein & Feinstein, 2001; Lester et al., 2007). Research has found that point-prevalence for
depression is estimated at approximately 30% (Lester et al., 2007) and anxiety point-prevalence
may be as high as 41% (Beiske et al., 2008). A study conducted by Hoang, Stenager, and
Stenager (2017) measured depression and anxiety, using the Hospital Anxiety and Depression
Scale (HADS; Zigmond & Snaith, 1983), among PwMS in the post-diagnostic period
(characterized as the first six weeks following diagnosis). The study found that the prevalence of
depression in this population was 49.2% (Hoang et al., 2017). The prevalence of anxiety in the
post-diagnostic period has been suggested to be approximately 34% (Lester et al., 2007).
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Research into the relationship between mood disorders and MS has yielded multiple potential
predictors for the increase in depression and anxiety in this population.
1.1.3.1

Predictors of Mood Disorders in PwMS

Predictors of mood disorders in PwMS include social isolation, unpredictable disease
course, adjustment/coping with illness, and decreased QOL (Beiske et al., 2008; Lester et al.,
2007; Rudick & Miller, 2008). Multiple studies have identified a link between unemployment
due to illness and depression, and highlight the impact of MS on an individual’s social inclusion
(Beiske et al., 2008; Rudick & Miller, 2008). Additionally, mood disorders are a significant
predictor of QOL among PwMS. QOL is defined as the ability to feel satisfaction from life,
despite disease (Benedict et al., 2005). Studies have (not surprisingly) consistently shown a
negative correlation between QOL and depression/anxiety (Beiske et al., 2008; Benedict et al.,
2005; Lester et al., 2007). QOL measures typically involve the assessment of physical disease
disability, fatigue, and CI (Benedict et al., 2005).
Another predictor of depression and anxiety in PwMS is the unpredictable disease course
(Lester et al., 2007; Rudick & Miller, 2008). As aforementioned, MS is a variable disease that
leaves PwMS wondering if or when the disease will exacerbate, and how severe the relapse will
be (Lester et al., 2007). As such, this near constant worry over the variability of the disease is
likely to have negative health impacts – not only on mental health variables, such as depression
and anxiety, but on the body’s reaction to the stress itself. More specific to MS, there is evidence
to suggest that stress exacerbates symptoms of the disease (van Noort, 1996). In relation to the
unpredictable nature of the illness, it is possible that trying to cope or adjust to the illness is
related to mood disorders (Lester et al., 2007; Rudick & Miller, 2008). Research suggests that
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this predictor is most closely related to the post-diagnostic prevalence of depression and anxiety
as the PwMS are still trying to understand the illness (Lester et al., 2007).
1.1.3.2

Correlates of Mood Disorders in PwMS

To date, many studies have investigated correlates of mood disorders in the MS population.
From this research, three main correlates have emerged: fatigue (Beiske et al., 2008; Kinsinger et
al., 2010; Lester, Stepleman, & Hughes, 2007), CI (Blair et al., 2016; DiGiuseppe et al., 2018;
Gill et al., 2019; Kinsinger et al., 2010; Lester et al., 2007; Malivoire et al., 2018; Morrow et al.,
2016; Rogers & Panegyres, 2007), and disease factors such as onset, duration, and disability
(Beiske et al., 2008; Lester et al., 2007).
Beiske et al. (2008) found that both age and early onset of the disease were significantly
related to depression, and that age, early onset, disease disability, and disease-related pain were
significantly related to anxiety. They found that the younger the individual was at diagnosis of
illness, the more depressed and anxious they were on the day of testing. Beiske et al. (2008) also
found that lower EDSS scores were associated with higher anxiety. On the other hand, higher
pain ratings were associated with higher anxiety, a finding that is consistent with earlier work by
Kalia and O’Connor (2005).
Another strong correlate of mood disorders in PwMS is CI. As mentioned above, CI
impacts many aspects of daily living, and so it is unsurprising that it is related to depression and
anxiety among in PwMS. Lester et al. (2007) found that CI accounts for the most variance in
depression and anxiety. They proposed that the cognitive symptoms of MS create a sense of
helplessness, leading to depression and anxiety.
Beiske et al. (2008) also found that depression is significantly associated with fatigue but
were unable to specify a directionality for the prediction – in other words, the fatigue may have
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been a result of depression, or the depression, may have been the result of the fatigue. Similarly,
the study evidence was equivocal with regards to the mediating effects of fatigue and depression
within the symptom model that was presented. Penner et al. (2015) found that pharmaceutical
treatment of fatigue reduced the depression experienced by PwMS, thus suggesting that the
relationship between depression and MS is mediated by fatigue.
1.2
1.2.1

Fatigue
Physical Fatigue and Cognitive Fatigue
Fatigue is the most debilitating symptom experienced by PwMS and it is also the most

common (Bailey, Channon, & Beaumont, 2007; Barak & Achiron, 2006; Paul, Beatty,
Schneider, Blanco, & Hames, 1998; Penner et al., 2015; Touzet, 2017). Fatigue experienced by
PwMS is reported to be an increased feeling of weakness, independent of activity level and time
of day, accompanied by a persistent and unusual feeling of tiredness (Barak & Achiron, 2006).
Fatigue can be broken down into two categories: physical or motor fatigue; and cognitive fatigue
(CF; Sindermann et al., 2018). Fatigue may also be objectively defined as a decline in
performance during a sustained activity. Physical fatigue may be measured by performance of
muscle contractions during a sustained activity, while CF is typically measured by evaluating
sustained performance on cognitive measures. While physical fatigue is a construct of muscle
weakness and decline in physical strength (Schwid et al., 2003), CF is a construct of information
processing speed, attention, executive function, and working memory (Bailey et al., 2007). CF is
known to negatively impact an individual’s everyday life, such as: talking, eating, cooking,
shopping, going to work or school, and driving (Touzet, 2017). While physical fatigue has been
associated with age, gender, physical dysfunction and disease duration, CF has not been found to
be correlated with these dimensions (Walker, Berard, Berrigan, Rees, & Freedman, 2012). Paul
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et al. (1998) demonstrated a positive correlation between cognitive and physical fatigue. CF is
often further broken down into two subcategories: objective CF and subjective CF (Bryant,
Chiaravalloti, & DeLuca, 2004).
1.2.2

Objective Cognitive Fatigue and Subjective Cognitive Fatigue
Objective CF is the measurement of decreased performance on or inability to sustain a

cognitive activity at a single point in time (Bryant et al., 2004). Subjective CF, then, is a
subjective, or self-reported measurement of CF, in which an individual reports on their own CF
over a period of time (Walker et al., 2012). Thus, in addition to differences in the method of
measurement, these constructs may differ in terms of their assessment of acute (objective CF)
versus chronic (subjective CF) impairment. Over the past few years, researchers have
endeavored to investigate the relationship between objective and subjective CF. Research thus
far has been quite heterogeneous, utilizing different measurement methods, which makes it
difficult to compare the results. Genova et al. (2013) used functional magnetic resonance
imaging to visualize the relationship between cognitive performance and perception of fatigue.
They found that brain activation matched self-reported levels of cognitive fatigue. Other studies
have used questionnaires and cognitive tasks to assess the relationship between objective and
subjective CF (e.g., Bailey et al., 2007; Berard, Smith, & Walker, 2019), but only one of these
studies demonstrated a statistically significant positive correlation between these variables
(Walker et al., 2012). Interestingly, the objective measurement of CF in this study did not result
in a statistically significant CF as compared with controls.
Similar results were seen by Golan et al. (2018), in a study exploring the impact of
subjective fatigue on cognitive function. These researchers examined the association between
cognitive function and subjective CF and found that subjective CF was not related to objective
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cognitive function. However, the specific findings of the research demonstrated an association
between subjective CF and independent measures of cognitive function. The constructs that were
related to subjective CF were: memory, attention, information processing speed, executive
function, and motor skills. Many of these constructs (i.e. memory, attention, information
processing speed, and executive function) are hallmarks of objective CF, so it is interesting that
when a calculation accounts for all cognitive function tasks, the association is diminished. It is,
however, important to note that the correlations between these factors and subject CF were weak.
In sum, while the preponderance of evidence within the literature would suggest that there
is no significant relationship between perception of CF and cognitive performance, there is still a
lot of variability in the tests that are used to conduct this research, suggesting that this question
remains undecided.
1.2.3

Measures of Objective CF
Tests for objective CF evaluate cognitive function or performance, such as: endurance,

attention, memory and information processing speed (Touzet, 2017). Some of the measures that
are commonly used to assess objective CF include:
1) Digit Ordering Test. This is a test of verbal working memory, in which seven digits are
presented, and must be recalled immediately in ascending numerical order for each trial.
This measure has 15 trials, and CF is calculated by comparing the first and last thirds of
the test (Schwid et al., 2003).
2) Boston Naming Test. The outcome of this measure is the number of correctly identified
images out of 60 (Bryant et al., 2004).
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3) Stroop Colour and Word Test. This task is used to measure attention, and individuals
completing this test must read colour names that are not printed in the colour of the word
(Bryant et al., 2004).
4) Word List Learning. This task, which presents 14 words to a participant, and asks that
he/she recall as many words from the list as possible, was created by the researchers for
the purpose of measuring how well PwMS can learn over a sustained period of time (Paul
et al., 1998).
5) The Gordon Distractibility Task. This test is used to assess vigilance, in which
individuals must react to number sequences presented in three different positions on the
computer screen, by pressing a key when the sequence appeared in the center (Paul et al.,
1998).
6) The Computerized Test of Information Processing. A test of reaction time and
vigilance in which individuals must press a key if words are not in order (Walker et al.,
2012).
7) The Paced Auditory Serial Addition Test. This is the “industry standard” for assessing
cognitive fatigue (PASAT; Gronwall, 1977; Morrow, Rosehart, & Johnson, 2015; Rao,
Leo, Bernardin, & Unverzagt, 1991; Schwid et al., 2003; Walker et al., 2012). It has been
validated for the MS population (Morrow et al., 2015), and when compared to the
previous measures of objective CF has consistently been found to be more sensitive, and
more accurate in assessing CF (Bryant et al., 2004; Schwid et al., 2003; Walker et al.,
2012). The task requires participants call out the sum of the last two single digit numbers
that are presented on an audio recording at a rate of one every three seconds. Participants
may make a total of 60 responses on the task, following the completion of a series of
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practice questions to ensure understanding of the test. For example, if the first four
numbers presented were: 5, 7, 3, and 2, the expected answers are: 12, 10 and 5. One of
the reasons the PASAT is such an efficient test for CF is because of the constructs that it
measures: information processing speed, working memory, and attention (Morrow et al.,
2015). The key to the task is that the individual completing the test must be attentive to
ensure they hear all the numbers presented, he/she must process the simple addition of the
last two numbers presented, and then keep the last heard number fresh for the next
number presented. The idea of the test is that an individual who is experiencing CF will
not be able to sustain their performance throughout the task, while an individual not
experiencing CF will improve the longer the task is performed. Thus, researchers using
this measure typically compute a CF variable by comparing the first and last thirds of the
test (Morrow et al., 2015; Walker et al., 2012).
1.2.4

Measures of Subjective CF
Measures of subjective CF are relatively simple when compared to objective CF testing.

All the tests for subjective CF are self-report questionnaires, as subjective CF is measuring an
individual’s perceived CF. The Fatigue Impact Scale (FIS) is a validated measure of subjective
CF (Fisk et al., 1994; Strober & Arnett, 2005) of subjective CF. The FIS is 36 questions relating
to the impact of fatigue on three dimensions of life: physical (10 items), cognitive (10 items), and
psychosocial (16 items). The Modified Fatigue Impact Scale (MFIS) was created for, and
validated within, the MS population (Learmonth et al., 2013). The MFIS is a shorter version of
the FIS that includes 10 items on cognitive fatigue, 9 items on physical fatigue, and 2 items on
psychosocial fatigue. Each of the subscales are evaluated using a five-point Likert scale ranging
from 0-4, 0 being “never”, and 4 being “almost always”. The MFIS yields a total score (the sum

13

of all items), and three scale scores calculated as the sum of the items within each subscale.
Examples of the questions are: “I have been clumsy and uncoordinated” (physical); “I have been
unable to think clearly” (cognitive); “I have been limited in my ability to do things away from
home” (psychosocial). The cognitive subscale of the MFIS has been used in the MS literature as
the primary assessment of subjective CF (Berard, Smith, & Walker, 2019), and due to the
multidimensionality of the test, it has been recommended to utilize the subscales over the total
score (Mills, Young, Pallant, & Tennant, 2010). The FIS and MFIS are the two most commonly
used subjective CF scales in literature.
While the FIS and MFIS are retrospective subjective CF scales, that assess subjective CF
over a four-week (one month) period, some studies testing the subjective/objective CF
relationship have created tests that measure subjective CF after every objective measure. Bailey
et al. (2007) asked participants to select a number from 0 (not at all) to 8 (extremely, the most
tired/fatigued I’ve ever been) to reflect their perceived fatigue or tiredness. To assess the extent
to which subjective fatigue was associated with objective fatigue, they conducted this assessment
at the outset of testing, and then again following every objective measure (participants completed
a total of four assessments). This testing framework allowed researchers to evaluate the change
in subjective fatigue during cognitive tasks. Another study adapted previously created scales to
measure subjective fatigue, modifying the scales to estimate current fatigue, rather than a
subjective aggregate of fatigue over the preceding month (Paul et al., 1998). These scales used a
five-point Likert scale that ask participants to select a number from 1 (not at all) to 5 (a great
deal) in their assessment of subjective cognitive (e.g., “do you currently have problems
concentrating?”) and physical (“are you having any problems with tiredness?”) fatigue. Paul et
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al. (1998) had participants complete these scales at the start of testing, and then again at the end
of testing, to gauge the change in subjective CF after completing the cognitive battery.
1.3

Cognitive Fatigue in PwMS
CF in PwMS has been well documented in the past and is known to have a large impact on

an individual’s daily life, resulting in a decreased quality of life (Barak & Achiron, 2006). Four
main predictors of CF in PwMS have emerged within the literature: information processing
speed, sleep quality, disease disability, and depression.
1.3.1

Information Processing Speed
Information processing speed is often assessed in clinical settings, as it is closely related to

CI and can help to determine the cognitive ability and CF of an individual (Benedict et al., 2001;
Morrow et al., 2015). Previous research has also shown a relationship between information
processing speed and mood disorders in PwMS (Bailey et al., 2007; Diamond, Johnson,
Kaufman, & Graves, 2008). Despite the fact that information processing speed has been
proposed as the underlying cause of CF in PwMS (Bailey et al., 2007), it is important to consider
the potential mediation of depressive symptoms, as depression has been demonstrated to be
associated with both CF and information processing speed (Golan et al., 2018; Morrison &
Stuifbergen, 2016; Sindermann et al., 2018).
Diamond et al. (2008) attempted to quantify the extent to which depression mediated the
relationship between information processing speed and CF. First, the study determined that
information processing speed, as measured by Visual Threshold Serial Addition Test, and
depression, as measured by the Center for Epidemiological Studies of Depression Scale (CESD), were significantly related. Next, the variability associated with mood and fatigue was
removed from the equation, to calculate the unique contribution of information processing speed.

15

The researchers concluded that mood and fatigue accounted for 66% of the variance in
information processing speed, but that mood and fatigue were not impactful on the relationship
between information processing speed and effortful processing (as measured by two cognitive
performance tasks, separate from CF).
In addition, research conducted by Golan et al. (2018), found a significant negative
correlation between subjective CF and information processing speed, meaning that as subjective
CF increased information processing speed decreased. After controlling for depression and
disease disability, however, the relationship between information processing speed and
subjective CF was diminished. This result could be attributed to the method of assessment used
for measuring information processing speed. Golan et al. (2018) used a computerized cognitive
testing battery that assessed multiple cognitive domains: memory, executive function, visualspatial processing, verbal function, motor skills, attention, and information processing speed.
When investigating information processing speed as a main predictor of CF, an information
processing speed specific test should be used in order to better compare the results of each
domain.
1.3.2

Sleep Quality
Sleep quality has been identified as an important predictor of both objective (Berard et al.,

2019) and subjective CF (Strober & Arnett, 2005), with the primary predictors of sleep quality
being sleep disturbances, day-time sleepiness, and sleep latency. Although often associated with
depression, research has found that sleep quality remains a unique predictor among PwMS for
both objective CF (Berard et al., 2019) and subjective CF (Strober & Arnett, 2005).
Strober and Arnett (2005) completed some of the earliest work in this domain – the
literature to this point was largely correlation-based, and thus the goal of this research was to

16

understand more about CF in PwMS. The study found that sleep quality, depression, and disease
disability were all predictive of CF in PwMS, with sleep quality accounting for the most
variance. When investigating the interrelatedness of the constructs, it was found that depression
and sleep quality were significantly correlated with each other. This significant association was
not due to item overlap across the questionnaires, as the researchers created a new Sleep
Composite derived from questions pertaining to sleep from the depression questionnaires used.
The researchers reviewed depression questionnaires (Beck Depression Inventory, Chicago
Multiscale Depression Inventory, and Sickness Impact Profile Sleep and Rest Scale), and
removed all items pertaining to sleep. They next composed a new questionnaire with a unique set
of eight items. An example of the questions on this Sleep Composite are: “Fitful Sleep” (Chicago
Multiscale Depression Inventory); “I sit around half-asleep” (Sickness Impact Profile); and,
“Difficulty Sleeping” (Beck Depression Inventory). While the Sleep Composite was useful for
the study, and the tests used to compose the composite have been validated, the Sleep Composite
as a whole was not a validated measurement of sleep quality.
Berard et al. (2019) sought to update the research by Strober and Arnett (2005) by
including a measure for objective CF, the PASAT. The study predicted that the results from
Strober and Arnett (2005) would translate to objective CF. For the most part, the hypothesis was
borne out: sleep quality was the best predictor, followed by depression. The study also found that
depression was the best predictor in sleep quality, suggesting that depression causes decreased
sleep quality, which is then predictive of CF. The study also found that sleep was significantly
associated with subjective CF, as measured by the MFIS. Unlike the previous research, disease
disability was not found to be predictive of CF; this is most likely due to the change from
subjective to objective CF.
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Another difference between the two studies is the sleep quality measure. Berard et al.
(2019), used the Pittsburgh Sleep Quality Index (PSQI; Buysse, Reynolds, Monk, Berman, &
Kupfer, 1989), while Strober and Arnett (2005) used a composite of “sleep items” from validated
depression measures. Psychometrically, the PSQI is a better choice of measurement tool, as it
has been validated as a whole, unlike the questionnaire created by Strober and Arnett (2005). It
measures seven components of sleep: subjective sleep quality, sleep latency, sleep duration,
habitual sleep efficiency, sleep disturbances, use of sleeping medication, and day-time
dysfunction. Participants are asked to think about the past month when completing the
questionnaire. The questionnaire is divided into Likert-scale questions (i.e., “not during the past
month”, “less than once a week”, “once or twice a week”, or “three or more times a week”), and
open-ended questions pertaining to sleep habits (e.g., How many hours of actual sleep do you get
at night?). Scores on each of the seven components range from 0 to 3, with a total score of five or
higher being indicative of poor sleep quality. The questionnaire can also be analysed by the
individual facets of sleep.
1.3.3

Disease Disability
As mentioned previously, disease disability as measured by the EDSS, is related to

information processing speed, depression, and CF (Berard et al., 2019; Golan et al., 2018;
Morrison & Stuifbergen, 2016; Strober & Arnett, 2005). Disease disability tends to predict only
a small amount of the variance in CF among PwMS (Schwid et al., 2003), with the relationship
often found to be mediated by other factors that are related to CF, such as sleep (Berard et al.,
2019; Strober & Arnett, 2005), physical fatigue (Golan et al., 2018), and depression (Bailey et
al., 2007; Sindermann et al., 2018).
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1.3.4

Depression
The construct most consistently associated with CF in PwMS is depression (Berard et al.,

2019; Golan et al., 2018; Morrison & Stuifbergen, 2016; Sindermann et al., 2018; Strober &
Arnett, 2005). Strober and Arnett (2005) found depression (as measured by the Chicago
Multiscale Depression Inventory) to be a unique predictor of CF. Berard et al. (2019) found that
depression (as measured by the Patient Health Questionnaire 9) was a unique predictor of CF, as
well as a significant predictor for sleep quality.
Morrison and Stuifbergen (2016) found depression (as measured by the CES-D) to be the
most significant predictor of subjective CF (as measured by the MFIS) among PwMS.
Furthermore, depression has been strongly associated with objective CF among PwMS, with
Golan et al. (2018) demonstrating that, although subjective and objective CF were not related,
depression (as measured by the Beck Depression Inventory; BDI) was significantly associated
with both objective and subjective CF. Golan et al. (2018) aimed to explore variables that impact
cognitive function, and determined that depression and not CF affected cognitive performance.
Surprisingly, the research on depression in PwMS remains equivocal, this is possibly due
to the variability in the assessments used to evaluate depression, such as the CES-D (Morrison &
Stuifbergen, 2016), and the BDI (Golan et al., 2018). This suggests that the next step in research
on predictors of CF in PwMS may be to standardize the measures used. The HADS is a measure
of depression and anxiety that is commonly used in the MS population, and might be a suitable
candidate for widespread adoption – particularly given that it simultaneously measures anxiety, a
variable that has been somewhat neglected in previous research on predictors of CF.
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1.4

Current Research
The primary objective of the current study was to investigate the predictors of both

subjective and objective CF in PwMS, and in accordance with previous research on the
predictors of these variables, we chose to include the following predictors: depression, disease
disability, sleep quality, and information processing speed. Unlike previous research, a new
variable was included: anxiety.
It was hypothesized that depression and anxiety would be the strongest predictors of both
objective and subjective CF in PwMS. It was also hypothesized that information processing
speed, sleep quality, and disease disability would be significant predictors of both objective and
subjective CF. Based on previous research, our secondary aim was to investigate the association
between objective and subjective CF. Furthermore, we hypothesized that there would be a strong
association between depression, anxiety, and sleep quality; a strong relationship between disease
disability, depression, and anxiety; and information processing speed would be strongly related
to depression, anxiety, sleep quality, and disease disability.
The PASAT was selected as the method of assessment for objective CF and the MFIS was
selected as the assessment of subjective CF. The HADS was selected for the assessment of
depression and anxiety, given that it has been validated within populations of PwMS. To ensure
comparability with studies that have previously used measures of sleep quality (e.g., Berard et
al., 2019), we selected the PSQI for evaluating sleep quality. In the literature, information
processing speed has been measured inconsistently, and as information processing speed can be
affected by a number of external variables (Diamond et al., 2008), two measurements were used.
The first was the Symbol Digit Modalities Test (SDMT) validated for the MS population
(Morrow et al., 2010), and conducted verbally to avoid any compounding motor processing
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impairments (Rao et al., 1991). The second is the ZVT (Oswald & Roth, 1987; Vernon, 1993), a
trail-making test that requires significantly less motor involvement than other established trail
making tests. Finally, the EDSS was used to assess disease disability for all participants, as this
is the current standard of practice for evaluating disease disability in PwMS.

21

1.5

References

Bailey, A., Channon, S., & Beaumont, J. G. (2007). The relationship between subjective fatigue
and cognitive fatigue in advanced multiple sclerosis. Multiple Sclerosis, 13(1), 73–80.
https://doi.org/10.1177/1352458506071162
Barak, Y., & Achiron, A. (2006). Cognitive fatigue in multiple sclerosis: Findings from a twowave screening project. Journal of the Neurological Sciences, 245(1–2), 73–76.
https://doi.org/10.1016/j.jns.2005.09.015
Beck, C. A., Metz, L. M., Svenson, L. W., & Patten, S. B. (2005). Regional variation of multiple
sclerosis prevalence in Canada. Multiple Sclerosis, 11(5), 516–519.
https://doi.org/10.1191/1352458505ms1192oa
Beiske, A. G., Svensson, E., Sandanger, I., Czujko, B., Pedersen, E. D., Aarseth, J. H., & Myhr,
K. M. (2008). Depression and anxiety amongst multiple sclerosis patients. European
Journal of Neurology, 15(3), 239–245. https://doi.org/10.1111/j.1468-1331.2007.02041.x
Benedict, R. H. B., Cookfair, D., Gavett, R., Gunther, M., Munschauer, F., Garg, N., &
Weinstock-Guttman, B. (2006). Validity of the minimal assessment of cognitive function
in multiple sclerosis (MACFIMS). Journal of the International Neuropsychological
Society, 12(04). https://doi.org/10.1017/S1355617706060723
Benedict, R. H. B., Priore, R. L., Miller, C., Munschauer, F., & Jacobs, L. (2001). Personality
Disorder in Multiple Sclerosis Correlates With Cognitive Impairment. The Journal of
Neuropsychiatry and Clinical Neurosciences, 13(1), 70–76.
https://doi.org/10.1176/jnp.13.1.70
Benedict, R. H. B., Wahlig, E., Bakshi, R., Fishman, I., Munschauer, F., Zivadinov, R., &
Weinstock-Guttman, B. (2005). Predicting quality of life in multiple sclerosis: accounting

22

for physical disability, fatigue, cognition, mood disorder, personality, and behavior
change. Journal of the Neurological Sciences, 231(1–2), 29–34.
https://doi.org/10.1016/j.jns.2004.12.009
Berard, J. A., Smith, A. M., & Walker, L. A. S. (2019). Predictive Models of Cognitive Fatigue
in Multiple Sclerosis. Archives of Clinical Neuropsychology, 34(1), 31–38.
https://doi.org/10.1093/arclin/acy014
Blair, M., Gill, S., Gutmanis, I., Smolewska, K., Warriner, E., & Morrow, S. A. (2016). The
mediating role of processing speed in the relationship between depressive symptoms and
cognitive function in multiple sclerosis. Journal of Clinical and Experimental
Neuropsychology, 38(7), 782–794. https://doi.org/10.1080/13803395.2016.1164124
Brissart, H., Morele, E., Baumann, C., Perf, M. Le, Leininger, M., Taillemite, L., … Debouverie,
M. (2013). Cognitive impairment among different clinical courses of multiple sclerosis.
Neurological Research, 35(8), 867–872. https://doi.org/10.1179/1743132813y.0000000232
Bryant, D., Chiaravalloti, N. D., & DeLuca, J. (2004). Objective Measurement of Cognitive
Fatigue in Multiple Sclerosis. Rehabilitation Psychology, 49(2), 114–122.
https://doi.org/10.1037/0090-5550.49.2.114
Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989). The
Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research.
Psychiatry Research, 28(2), 193–213.
Carone, D. A., Benedict, R. H. B., Munschauer, F. E. M., Fishman, I., & Weinstock-Guttman, B.
(2005). Interpreting patient/informant discrepancies of reported cognitive symptoms in
MS. Journal of the International Neuropsychological Society, 11(05).
https://doi.org/10.1017/S135561770505068X

23

Chiaravalloti, N. D., & DeLuca, J. (2008). Cognitive impairment in multiple sclerosis. The
Lancet Neurology, 7(12), 1139–1151. https://doi.org/10.1016/S1474-4422(08)70259-X
Chylova, M., van Dijk, J. P., Rosenberger, J., Nagyova, I., Gavelova, M., Gdovinova, Z., &
Groothoff, J. W. (2009). P02-211 Depression, anxiety and health status in patients with
multiple sclerosis. European Psychiatry, 24, S901. https://doi.org/10.1016/S09249338(09)71134-4
Diamond, B. J., Johnson, S., Kaufman, M., & Graves, L. (2008). Relationships between
information processing, depression, fatigue and cognition in multiple sclerosis. Archives
of Clinical Neuropsychology, 23(2), 189–199. https://doi.org/10.1016/j.acn.2007.10.002
DiGiuseppe, G., Blair, M., & Morrow, S. A. (2018). Prevalence of cognitive impairment in
newly diagnosed relapsing-remitting multiple sclerosis (pp. 153–157). pp. 153–157.
Feinstein, A., & Feinstein, K. (2001). Depression associated with multiple sclerosis. Journal of
Affective Disorders, 66(2–3), 193–198. https://doi.org/10.1016/S0165-0327(00)00298-6
Feuillet, L., Reuter, F., Audoin, B., Malikova, I., Barrau, K., Cherif, A. A., & Pelletier, J. (2007).
Early cognitive impairment in patients with clinically isolated syndrome suggestive of
multiple sclerosis. Multiple Sclerosis, 13(1), 124–127.
https://doi.org/10.1177/1352458506071196
Fisk, J. D., Ritvo, P. G., Ross, L., Haase, D. A., Marrie, T. J., & Schlech, W. F. (1994).
Measuring the Functional Impact of Fatigue: Initial Validation of the Fatigue Impact
Scale. Clinical Infectious Diseases, 18(Supplement_1), S79–S83.
https://doi.org/10.1093/clinids/18.Supplement_1.S79
Freedman, M. S., Selchen, D., Arnold, D. L., Prat, A., Banwell, B., Yeung, M., … Lapierre, Y.
(2013). Treatment Optimization in MS: Canadian MS Working Group Updated

24

Recommendations. Canadian Journal of Neurological Sciences, 40(3), 307–323.
https://doi.org/10.1017/S0317167100014244
Gill, S., Santo, J., Blair, M., & Morrow, S. A. (2019). Depressive Symptoms Are Associated
With More Negative Functional Outcomes Than Anxiety Symptoms in Persons With
Multiple Sclerosis. The Journal of Neuropsychiatry and Clinical Neurosciences, 31(1), 37–
42. https://doi.org/10.1176/appi.neuropsych.18010011
Genova, H. M., Rajagopalan, V., DeLuca, J., Das, A., Binder, A., Arjunan, A., … Wylie, G.
(2013). Examination of Cognitive Fatigue in Multiple Sclerosis using Functional
Magnetic Resonance Imaging and Diffusion Tensor Imaging. PLoS ONE, 8(11), e78811.
https://doi.org/10.1371/journal.pone.0078811
Glanz, B. I., Healy, B. C., Hviid, L. E., Chitnis, T., & Weiner, H. L. (2012). Cognitive
deterioration in patients with early multiple sclerosis: a 5-year study. Journal of
Neurology, Neurosurgery & Psychiatry, 83(1), 38–43.
https://doi.org/10.1136/jnnp.2010.237834
Golan, D., Doniger, G. M., Wissemann, K., Zarif, M., Bumstead, B., Buhse, M., … Gudesblatt,
M. (2018). The impact of subjective cognitive fatigue and depression on cognitive
function in patients with multiple sclerosis. Multiple Sclerosis, 24(2), 196–204.
https://doi.org/10.1177/1352458517695470
Gronwall, D. M. A. (1977). Paced Auditory Serial-Addition Task: A Measure of Recovery from
Concussion. Perceptual and Motor Skills, 44(2), 367–373.
https://doi.org/10.2466/pms.1977.44.2.367
Hoang, H., Stenager, E., & Stenager, E. (2017). The risk of depression and anxiety in the postdiagnostic period of multiple sclerosis measured by screening instruments and structured

25

interviews. European Psychiatry, 41, S236.
https://doi.org/10.1016/j.eurpsy.2017.01.2252
Kalia, L. V., & O’Connor, P. W. (2005). Severity of chronic pain and its relationship to quality
of life in multiple sclerosis. Multiple Sclerosis, 11(3), 322–327.
https://doi.org/10.1191/1352458505ms1168oa
Kinsinger, S. W., Lattie, E., & Mohr, D. C. (2010). Relationship between depression, fatigue,
subjetive cognitive impairment, and objective neuropsychological functioning in patients
with multiple sclerosis (pp. 573–580). pp. 573–580.
Kurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability
status scale (EDSS). Neurology, 33(11), 1444–1444.
https://doi.org/10.1212/WNL.33.11.1444
Learmonth, Y. C., Dlugonski, D., Pilutti, L. A., Sandroff, B. M., Klaren, R., & Motl, R. W.
(2013). Psychometric properties of the Fatigue Severity Scale and the Modified Fatigue
Impact Scale. Journal of the Neurological Sciences, 331(1–2), 102–107.
https://doi.org/10.1016/j.jns.2013.05.023
Lester, K., Stepleman, L., & Hughes, M. (2007). The Association of Illness Severity, SelfReported Cognitive Impairment, and Perceived Illness Management with Depression and
Anxiety in a Multiple Sclerosis Clinic Population. Journal of Behavioral Medicine, 30(2),
177–186. https://doi.org/10.1007/s10865-007-9095-6
Malivoire, B. L., Hare, C. J., & Hart, T. L. (2018). Psychological symptoms and perceived
cognitive impairment in multiple sclerosis: The role of rumination. Rehabilitation
Psychology, 63(2), 286–294. https://doi.org/10.1037/rep0000180
Mills, R. J., Young, C. A., Pallant, J. F., & Tennant, A. (2010). Rasch analysis of the Modified

26

Fatigue Impact Scale (MFIS) in multiple sclerosis. Journal of Neurology, Neurosurgery and
Psychiatry, 81(9), 1049–1051. https://doi.org/10.1136/jnnp.2008.151340
Morrison, J. D., & Stuifbergen, A. K. (2016). Predictors of Fatigue Impact in Persons With
Long-Standing Multiple Sclerosis: Journal of Neuroscience Nursing, 48(3), 143–150.
https://doi.org/10.1097/JNN.0000000000000208
Morrow, S. A., O’Connor, P. W., Polman, C. H., Goodman, A. D., Kappos, L., Lublin, F. D., …
Benedict, R. H. B. (2010). Evaluation of the symbol digit modalities test (SDMT) and
MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS
patients over 48 weeks. Multiple Sclerosis, 16(11), 1385–1392.
https://doi.org/10.1177/1352458510378021
Morrow, S. A., Rosehart, H., & Johnson, A. M. (2015). Diagnosis and quantification of cognitive
fatigue in multiple sclerosis. Cognitive and Behavioral Neurology, 28(1), 27–32.
https://doi.org/10.1097/WNN.0000000000000050
Morrow, S. A., Rosehart, H., & Pantazopoulos, K. (2016). Anxiety and Depressive Symptoms
Are Associated With Worse Performance on Objective Cognitive Tests in MS. The Journal
of Neuropsychiatry and Clinical Neurosciences, 28(2), 118–123.
https://doi.org/10.1176/appi.neuropsych.15070167
Oswald, W. D., & Roth, E. (1987). Der Zahlen Verbindungs Test (ZVT). Handanweisung
(Manual). Gottingen, Germany.: Hogrefe.
Paty, D. W., Noseworthy, J. H., & Ebers, G. C. (1998). Diagnosis of Multiple Sclerosis. In D. W.
Paty & G. C. Ebers (Eds.), Multiple Sclerosis (pp. 85–91). Philadelphia, PA: F.A. Davis
Co.

27

Paul, R. H., Beatty, W. W., Schneider, R., Blanco, C. R., & Hames, K. A. (1998). Cognitive and
Physical Fatigue in Multiple Sclerosis: Relations Between Self-Report and Objective
Performance. Applied Neuropsychology, 5(3), 143–148.
https://doi.org/10.1207/s15324826an0503_5
Penner, I. K., Sivertsdotter, E. C., Celius, E. G., Fuchs, S., Schreiber, K., Berkö, S., …
TYNERGY trial investigators. (2015). Improvement in Fatigue during Natalizumab
Treatment is Linked to Improvement in Depression and Day-Time Sleepiness. Frontiers
in Neurology, 6(18). https://doi.org/10.3389/fneur.2015.00018
Rao, S. M., Leo, G. J., Bernardin, L., & Unverzagt, F. (1991). Cognitive dysfunction in multiple
sclerosis.: I. Frequency, patterns, and prediction. Neurology, 41(5), 685–691.
https://doi.org/10.1212/WNL.41.5.685
Rogers, J. M., & Panegyres, P. K. (2007). Cognitive impairment in multiple sclerosis: Evidencebased analysis and recommendations. Journal of Clinical Neuroscience, 14(10), 919–927.
https://doi.org/10.1016/j.jocn.2007.02.006
Rudick, R. A., & Miller, D. M. (2008). Health-Related Quality of Life in Multiple Sclerosis:
Current Evidence, Measurement and Effects of Disease Severity and Treatment. CNS
Drugs, 22(10), 827–839. https://doi.org/10.2165/00023210-200822100-00004
Schultheis, M. T., Weisser, V., Ang, J., Elovic, E., Nead, R., Sestito, N., … Millis, S. R. (2010).
Examining the Relationship Between Cognition and Driving Performance in Multiple
Sclerosis. Archives of Physical Medicine and Rehabilitation, 91(3), 465–473.
https://doi.org/10.1016/j.apmr.2009.09.026

28

Schwid, S. R., Tyler, C. M., Scheid, E. A., Weinstein, A., Goodman, A. D., & McDermott, M. P.
(2003). Cognitive fatigue during a test requiring sustained attention: a pilot study.
Multiple Sclerosis, 9(5), 503–508. https://doi.org/10.1191/1352458503ms946oa
Sindermann, C., Saliger, J., Nielsen, J., Karbe, H., Markett, S., Stavrou, M., & Montag, C.
(2018). Personality and Primary Emotional Traits: Disentangling Multiple Sclerosis
Related Fatigue and Depression. Archives of Clinical Neuropsychology, 33(5), 552–561.
https://doi.org/10.1093/arclin/acx104
Strober, L., & Arnett, P. (2005). An examination of four models predicting fatigue in multiple
sclerosis. Archives of Clinical Neuropsychology, 20(5), 631–646.
https://doi.org/10.1016/j.acn.2005.04.002
Touzet, C. (2017). Cognitive fatigue: an impaired cortical inhibitory replenishment. Brain Injury,
31(12), 1625–1631. https://doi.org/10.1080/02699052.2017.1344300
van Noort, J. M. (1996). Multiple sclerosis: an altered immune response or an altered stress
response? Journal of Molecular Medicine, 74(6), 285–296.
https://doi.org/10.1007/BF00207506
Vernon, P. A. (1993). Der Zahlen-Verbindungs-Test and other trail-making correlates of general
intelligence. Personality and Individual Differences, 14(1), 35–40.
https://doi.org/10.1016/0191-8869(93)90172-Y
Viner, R., Fiest, K. M., Bulloch, A. G. M., Williams, J. V. A., Lavorato, D. H., Berzins, S., …
Patten, S. B. (2014). Point prevalence and correlates of depression in a national
community sample with multiple sclerosis. General Hospital Psychiatry, 36(3), 352–354.
https://doi.org/10.1016/j.genhosppsych.2013.12.011

29

Walker, L. A. S., Berard, J. A., Berrigan, L. I., Rees, L. M., & Freedman, M. S. (2012).
Detecting cognitive fatigue in multiple sclerosis: Method matters. Journal of the
Neurological Sciences, 316(1–2), 86–92. https://doi.org/10.1016/j.jns.2012.01.021
Zigmond, A. S., & Snaith, R. P. (1983). The Hospital Anxiety and Depression Scale. Acta
Psychiatrica Scandinavica, 67(6), 361–370. https://doi.org/10.1111/j.16000447.1983.tb09716.x

30

Chapter 2
2.1

Introduction
Multiple Sclerosis (MS) is a debilitating disease caused by inflammation in the central

nervous system resulting in demyelination (Paty, Noseworthy, & Ebers, 1998). In addition to the
more well-known physical symptoms of the disease, persons with Multiple Sclerosis (PwMS)
suffer from a wide array of cognitive symptoms, including cognitive impairment (Benedict et al.,
2005; Rao, Leo, Bernardin, & Unverzagt, 1991), and cognitive fatigue (CF; Berard, Smith, &
Walker, 2019; Morrow, Rosehart, & Johnson, 2015; Schwid et al., 2003). CF has been defined as
a worsening of cognitive performance over the course of a sustained cognitive activity task
(Schwid et al., 2003). It may be objectively measured using the Paced Auditory Serial Addition
Test (PASAT), a cognitive test that assesses both processing speed and working memory (Rao et
al., 1991). Morrow et al. (2015) presented evidence to suggest that the PASAT is a valid method
of measuring CF in PwMS, by comparing the first third of the test to the last third of the test.
Alternatively, it is possible to assess perceived or subjective cognitive fatigue, using self-report
questionnaires, such as the cognitive subscale of the Modified Fatigue Impact Scale (MFIS; Fisk
et al., 1994)
While objective and subjective CF have been well documented in the MS population
(Barak & Achiron, 2006; Bryant, Chiaravalloti, & DeLuca, 2004) there has been much debate
over the relationship between objective and subjective CF (Bailey, Channon, & Beaumont, 2007;
Berard et al., 2019; Paul, Beatty, Schneider, Blanco, & Hames, 1998; Walker, Berard, Berrigan,
Rees, & Freedman, 2012). To date, some researchers have found a significant correlation
between objective CF and subjective CF (Walker et al., 2012), while others have not (Bailey et
al., 2007; Berard et al., 2019; Paul et al., 1998).
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Another complaint often seen in PwMS is depression (Berard et al., 2019; Fricska-Nagy et
al., 2016). Although PwMS often experience both depression and cognitive fatigue, the
relationship between these symptoms is not well understood, as it is difficult to identify whether
there is a direct causal link between the symptoms, or whether the relationship between
depression and cognitive fatigue is due to other characteristics of MS. Research by Berard and
colleagues (2019) found that although depression was significantly correlated with CF,
depression was not a significant predictor of CF, but rather a predictor of sleep quality, which
was the strongest predictor of objective CF. Contrarily, Morrison and Stuifbergen (2016) found
that depressive symptoms are the strongest direct predictor of CF in PwMS. A key source of
variability within the research literature may relate to the measurement tools applied to the
assessment of depression. The Hospital Anxiety and Depression Scale (HADS; Zigmond &
Snaith, 1983) is a validated and often-used measure of depression and anxiety in PwMS
(Honarmand & Feinstein, 2009). It is a quick and efficient test for depression – and its ability to
also provide insight into patient anxiety makes it ideal for studies of cognitive fatigue, as this has
been recommended as an important dimension for further study among PwMS (Berard et al.,
2019).
Past research in the non-MS population, has further shown an association between
depression and slowed information processing speed (Sheline et al., 2006). McDermott and
Ebmeier (2009) conducted a meta-analysis that found significant correlations among measures of
depression severity, information processing speed, and memory. It has been demonstrated that
individuals within the non-MS population that experience both depression and CF have deficits
in executive function, working memory, and information processing speed (Papakostas, 2014).
Within the MS population, Diamond, Johnson, Kaufman, and Graves (2008) found that
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decreased processing speed was significantly correlated with both depression and fatigue as
measured by MFIS. Researchers were, however, unable to determine the direction of the
relationship among the three variables.
The current study aimed to investigate the extent to which objective and subjective CF can
be predicted by depression, anxiety, sleep quality, disease disability, and information processing
speed. To this end, participants were asked to complete: (1) the Paced Auditory Serial Addition
Test (PASAT) to assess levels of objective cognitive fatigue; (2) the Symbol Digit Modalities
Test (SDMT) and the Zahlen Verbindungs Test (ZVT) to assess information processing speed;
(3) the Hospital Anxiety and Depression Scale (HADS) to assess anxiety and depression; (4) the
Expanded Disability Status Scale (EDSS) to assess the disability of their MS symptoms; (5) the
Pittsburgh Sleep Quality Index (PSQI) to assess sleep quality; and (6) the Modified Fatigue
Impact Scale (MFIS) to assess overall fatigue and subjective CF. It was hypothesized that the
combination of variables would predict both objective and subjective CF, and that there would
not be a relationship between objective and subjective CF.
2.2
2.2.1

Methods
Participants
This study recruited 55 PwMS (37 females), aged 20 to 62 (M = 44.23, SD = 11.19) from

an outpatient MS clinic in London, Ontario, Canada, between January and April of 2019.
Participants were included in the study if they were over the age of 18, fluent in English, and had
a diagnosis of either Relapsing/Remitting, Secondary Progressive or Primary Progressive MS.
Participants were excluded from participation if they had been diagnosed with a neurological
disorder (other than MS), and if they used daily antipsychotics, narcotics, amphetamine
stimulants, cannabis or benzodiazepines (other than at night). Two participants were excluded (n
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= 53) from the analysis. One participant decided to stop testing due to fatigue level, and another
participant was excluded due to cannabis usage on the day of testing.
2.2.2

Measures

Demographics. Demographic information was collected within a demographic interview, at the
outset of the study. Any information that a participant was unable to provide was collected (with
permission from the participant) from his or her medical chart. Medication and psychological
history were collected but used only to ensure that no exclusion criteria were met.
Paced Auditory Serial Addition Test (PASAT). The PASAT is a validated measure of cognitive
fatigue in PwMS that measures working memory and processing speed (Morrow et al., 2015).
The task requires participants to call out the sum of the last two single digit numbers that are
presented on an audio recording at a rate of one every three seconds. Participants may make a
total of 60 responses on the task, following the completion of a series of practice questions to
ensure understanding of the task. Per the recommendations of Morrow et al. (2015), a “cognitive
fatigue score”, the PASAT CF, was generated by subtracting the number of correct responses
given during the first third of the PASAT, from the number of correct responses given during the
last third of the PASAT. In this way, it may be seen that participants with a negative score on
this measure are demonstrating a reduced level of function over the course of the test (i.e., their
performance on the last third of the test was worse than their performance on the first third of the
test), which may be indicative of cognitive fatigue.
Symbol Digit Modalities Test (SDMT). The SDMT is a part of the standard battery of
neuropsychological tests for PwMS and is used to assess information processing speed (Morrow
et al., 2010). In the current study, the SDMT was conducted orally to avoid any compounding
motor processing impairments (Rao et al., 1991). The SDMT is a symbol-digit matching test, in
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which the numbers 1-9 are paired with a unique symbol located in a key at the top of the test
page. The task gives participants 90 seconds to call out as many correctly matched numbers as
possible without missing any. Participants were given ten practice trials, and if the participant
responded incorrectly during the practice questions, the researcher corrected the participants, and
indicated how to correctly identify the corresponding number. As this test was performed orally,
the researcher kept score of correct and incorrect numbers for the participant on a duplicate test
page the participant did not see. The number of correctly identified symbols in the allotted time
represents an individual’s score on the test, with the high score being 110.
Hospital Anxiety and Depression Scale (HADS). The HADS was used to assess participant
anxiety and depression (Honarmand & Feinstein, 2009). There are 14 questions total (7 questions
for anxiety and 7 questions for depression), with scores for each question ranging from 0-3. For
example, “I feel cheerful” measures depression, and the possible responses are: (3) “Not at all”,
(2) “Not often”, (1) “Sometimes”, and (0) “Most of the time”. Scores on the HADS are
interpreted as continuous variables, with a total score of 42, or scale scores ranging from 0-21.
Pittsburgh Sleep Quality Index (PSQI). The PSQI is a self-report questionnaire that measures an
individual’s sleep quality (Buysse, Reynolds, Monk, Berman, & Kupfer, 1989). The PSQI
investigates 7 components of sleep: subjective sleep quality, latency, duration, efficiency,
disturbances, medications, and daytime dysfunction. Participants are asked to think about the
past month when completing the questionnaire. The questionnaire is divided into Likert-scale
questions (i.e., “not during the past month”, “less than once a week”, “once or twice a week”, or
“three or more times a week”), and open-ended questions pertaining to sleep habits (e.g., “How
many hours of actual sleep do you get at night?”). Scores on each of these components range
from 0 to 3 with a total score ranging from 0-21.
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Der Zahlen Verbindungs Test (ZVT). The ZVT (Oswald & Roth, 1987) was used as a
secondary analysis of information processing speed, investigating trail-making abilities.
Although the ZVT has not previously been used to assess information processing speed in the
MS population, it has a high reliability, and has been shown to be an effective measure of
information processing speed (Vernon, 1993). In addition, the ZVT is a fairly simple task that
takes only 45 seconds to complete. The ZVT, as used in this study, is administered on a single
sheet of paper with circles numbered from 1-90 placed at random (see Appendix A). For this
task, participants were asked to connect the numbered circles in ascending numerical order as
quickly as possible, beginning with the circle marked “start” (1). The test is scored by the highest
number the participant reached, minus the number of errors made. For the purposes of this test,
skipped numbers are also considered to be errors.
Modified Fatigue Impact Scale (MFIS). The MFIS is a self-report questionnaire that is widely
used as a fatigue scale for the MS population (Learmonth et al., 2013). Fatigue is assessed on
three subscales: physical (9 items; e.g., “I have been clumsy and uncoordinated); cognitive (10
items; e.g., “I have been unable to think clearly”); and psychosocial (2 items; e.g., “I have been
limited in my ability to do things away from home”). Each of the 21 questions have a five-point
Likert scale ranging from 0-4, 0 being “never”, and 4 being “almost always”. This test yields a
total score (the sum of all items), and three scale scores calculated as the sum of the items within
each subscale. The cognitive subscale of the MFIS is the measurement of subjective CF in the
current study. The cognitive subscale of the MFIS has been used in the MS literature as the
primary assessment of subjective CF (Berard, Smith, & Walker, 2019), and due to the
multidimensionality of the test, it has been recommended to utilize the subscales over the total
score (Mills, Young, Pallant, & Tennant, 2010).
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2.2.3

Procedure
All participants completed the test battery in the same order: (1) PASAT; (2) SDMT; (3)

HADS; (4) PSQI; (5) ZVT; and (6) MFIS. Participants who had completed any of these tests
within the past 6 months were not re-tested, with the previous testing result added to the study
data.
2.3

Results
Table 2.1 summarizes the demographic and disease characteristics of the sample of PwMS

used in the current study. The sample is primarily Caucasian (87%), with 77% of individuals
completing post-secondary education, and 40% of individuals unemployed due to disability.
Pearson correlations suggested statistically significant relationships between a number of
variables (see Table 2.2). As expected, age is significantly negatively correlated with both the
SDMT (r = -.48, p < .001) and the ZVT (r = -.30, p < .001). Age is also significantly positively
correlated with disease disability (r = .42, p < .001). Disease disability is associated with
information processing speed, as measured by both the SDMT (r = -.45, p < .001) and the ZVT
(r = -.47, p < .001). Disease disability is also correlated with depression (r = .34, p = .01). This
suggests that as disease disability increases, individuals are more likely to have a slower
information processing speed and are more likely to show symptoms of depression.
Objective CF and subjective CF were not significantly related (r = -.16). Of note, the
objective CF measure, the PASAT CF, did not demonstrate a statistically significant relationship
with any of the collected variables. The scale used to assess subjective CF (the cognitive scale of
the MFIS), however, demonstrated a statistically significant relationship with the SDMT (r = .29, p = .05), ZVT (r = -.32, p = .03), HADS depression (r = .61, p < .001), HADS anxiety (r =
.54, p < .001), and the total PSQI (r = .33, p = .02).
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Table 2.1 Descriptive Characteristics of Participants
Participants (n = 53)
Demographic information
Age (years)
Mean ± standard deviation
44.23 ± 11.19
Range
20-62
Sex
Male
16
Female
37
Ethnicity
Caucasian
46
African Canadian
2
First Nations
4
Other
1
Marital Status
Single or Divorced/Separated
22
Married or Cohabitating
31
Education
£ High school
12
Post-Secondary
41
Employment
Working (Full-Time: Part-Time)
22:8
Unemployed due to disability
21
Retired
2
MS Characteristics
Type
Relapsing-Remitting
Secondary Progressive
Primary Progressive
Disease Duration
Mean ± standard deviation
Range
Expanded Disability Status Scale
Median ± standard deviation

47
5
1
13.25 ± 8.41
1-36
2.0 ± 1.71
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Table 2.2 Zero-Order Correlations Among Variables.
Measure
1 Age

1
—

2
—

3
—

4
—

5
—

6
—

7
—

8
—

9
—

2 EDSS

.42**

—

—

—

—

—

—

—

—

3 PASAT
CF
4 MFIS
Cognitive
5 SDMT

.22

.09

—

—

—

—

—

—

—

.07

.21

-.16

—

—

—

—

—

—

-.48 **

-.45**

-.22

-.29*

—

—

—

—

—

6 ZVT

-.30*

-.47**

-.14

-.32*

.75**

—

—

—

—

.34*

.03

.61**

-.20

-.31*

—

—

—

.11

-.11

.54**

.05

-.08

.69**

—

—

.10

.03

.33*

-.19

-.22

.39**

.39**

—

7 HADS
.14
Depression
8 HADS
-.16
Anxiety
9 PSQI
.08
Total

Note. *p = .05, **p <.001.
As there were no statistically significant zero-order correlations with objective CF, we
did not carry out a direct entry linear regression that evaluated all of these variables
simultaneously. Subjective CF, however, demonstrated statistically significant relationships with
all of the experimental variables we measured. Thus, it is important to evaluate the extent to
which these variables are predictive of subjective CF when relationships among variables are
controlled. Direct entry regression suggests a strong predictive equation when all six variables
are used, R2adj = .384 [F (6, 40) = 5.783, p = .0002]. A summary of the model coefficients is
presented in Table 2.3. This regression suggests that there is a statistically significant unique
contribution from both the SDMT and depression. Furthermore, anxiety approached significance
as a unique predictor within the model.
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As it is possible that the prediction of subjective CF by depression is mediated by
information processing speed, further analyses were conducted to calculate the potential
mediating effect. Four steps were completed in testing for this mediation effect.
Table 2.3 Subjective CF Regression Analysis
Variable
b
SE
t
p
EDSS
-.563
.747
-.754
.455
ZVT
.023
.101
.227
.821
SDMT
-.249
.123
-2.024
.049*
Depression .844
.400
2.109
.041*
Anxiety
.611
.320
1.908
.064
Sleep
.145
.291
.486
.629
Quality
Note. Subjective CF as measured by the cognitive
subscale on the MFIS. Depression as measured by the
HADS depression subscale, Anxiety as measured by the
HADS anxiety subscale, Sleep Quality as measured by
the total score on the PSQI. * statistically significant at
p = .05.
First, it is necessary to demonstrate a statistically significant correlation between
depression and subjective CF. This is illustrated in Table 2.2, r = .61, t(47) = 5.23, p < .001.
The second step is to demonstrate a statistically significant correlation between depression
and information processing speed – and this relationship is also illustrated in Table 2.2. As there
are two measures of information processing speed, both scores were considered. The SDMT, a
test of sustained attention, does not demonstrate a statistically significant relationship (r = -.20).
The ZVT, however, a rapid decision-making test, did demonstrate a statistically significant
relationship with depression, r = -.31, t(49) = 2.32, p = .025. This suggests that individuals who
are more depressed are more likely to demonstrate slowed information processing speed.
Third, we need to demonstrate a statistically significant relationship between information
processing speed and subjective CF. The ZVT is significantly correlated with subjective CF, r =
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-.32, t(45) = 2.30, p = .026. This relationship suggests that individuals with faster information
processing speed are less likely to self-report CF.
The final step is to demonstrate that depression is less predictive of subjective CF when
information processing speed is controlled within the regression analysis. To evaluate the effect
of the indirect path between depression and subjective CF, Sobel’s (1982) indirect test for
mediation was used. The analysis suggested that including information processing speed as a
mediator changes the path coefficient between depression and subjective CF by .116, which is
not statistically significant, z = 1.09. This finding suggests that although both depression and
information processing speed are correlated with subjective CF, information processing speed
does not completely mediate the relationship between depression and subjective CF.
The PSQI is a multidimensional measure of sleep quality, and so it is worthwhile
considering the extent to which each of the individual subscales are predictive of subjective CF.
Zero-order correlations among the PSQI subscales, and subjective CF, are presented in Table
2.4. Interestingly, when we regress all seven subscales of the PSQI onto subjective CF, we find
a statistically significant predictive relationship, R2adj = .21 [F (7, 41) = 2.84, p = .017].
Additionally, as seen in Table 2.5, only three components of sleep quality were found to be
statistically significant at the univariate level: subjective sleep quality (p = .014), sleep latency (p
= .038), and sleep duration (p = .028).
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Table 2.4 PSQI Component Correlations
Measure
1 MFIS
Cognitive
2 PSQI total

1
—

2
—

C1
—

C2
—

C3
—

C4
—

C5
—

C6
—

C7
—

.33*

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

.50**

—

—

—

—

—

—

.56**

.56**

—

—

—

—

—

.29*

.46**

.51**

—

—

—

—

.22

.31*

.08

.20

—

—

—

.19

.16

.05

.06

.04

—

—

.38*

.34*

.03

.06

.52**

.17

—

C1
.39*
.71**
Subjective
Sleep
Quality
C2 Sleep
.38*
.78**
Latency
C3 Sleep
.09
.65**
Duration
C4 Sleep
.16
.61**
Efficiency
C5 Sleep
.18
.48**
Disturbances
C6
-.03
.47**
Medication
for Sleeping
C7 Daytime .33*
.56**
Dysfunction
Note. *p = .05, **p <.001.
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Table 2.5 Subjective CF Regression Analysis as Predicted by the PSQI
Variable
Subjective Sleep
Quality
Sleep Latency

5.235

b

SE
2.039

t
2.567

p
.014*

3.253

1.513

2.150

.038*

Sleep Duration

-4.202

1.852

-2.268

.028*

Sleep Efficiency

.682

1.357

.503

.617

-.161

.873

-1.101

.278

.678

.502

Sleep
-.364
2.257
Disturbances
Medication for
-1.007
.914
Sleeping
Daytime
1.324
1.953
Dysfunction
Note. * statistically significant at p = .05.

Sobel’s (1982) indirect test for mediation was used to evaluate any mediating effect of
depression on the three components of sleep quality. These findings suggest that although sleep
quality and depression correlate with subjective CF, depression does not mediate the relationship
between sleep quality and subjective CF.
2.4
2.4.1

Discussion
Findings
The current research conducted two regression analyses, one for subjective CF and one for

objective CF. Similar to the findings of Bailey et al. (2007) no significant predictors of objective
CF were observed within these data. Subjective CF was, however, found to be predicted by
depression, anxiety, information processing speed, sleep quality and disease disability.
Depression and information processing speed were found to be unique significant predictors of
subjective CF in PwMS – and subsequent mediator analyses suggested that these factors had a
direct effect on subjective CF. Although not statistically significant, anxiety showed a
substantive relationship with subjective CF that might be worthy of future research. Interestingly,

43

neither sleep quality nor disease disability were found to be uniquely predictive of subjective CF
– a result that runs contrary to previously reported findings within the literature (Berard et al.,
2019; Strober & Arnett, 2005). This may be reflective of the inclusion of information processing
speed and anxiety within the testing battery, as these two variables are not typically included
within test batteries that are intended to explore predictors of CF and perhaps reduced the effect
of sleep quality and disease disability.
It was also found that only one test of information processing was predictive of subjective
CF within the simultaneous regression equation. While both the SDMT and ZVT were correlated
with subjective CF, only the SDMT was a statistically significant predictor within the final
equation. There are two potential reasons for this finding. First, this could be due to the different
mechanisms of information processing the tests are measuring. The ZVT is a trail-making test,
looking for immediate decisions and quick action, while the SDMT measures learning, working
memory, and attention. The other potential reason for the difference is that the ZVT requires the
individual to use a pen to connect the circles while the SDMT was administered orally to avoid
any potential motor involvement. As disease disability is significantly related to both the SDMT
and ZVT, it follows that the slower the information processing speed, the worse the disease
disability. As higher EDSS scores relate to motor impairment, this could explain lower scores on
the ZVT as it becomes more difficult to draw.
Interestingly, sleep quality was not found to be significantly predictive of subjective CF
when combined with the other variables. However, when evaluating the relationship between
subjective CF and the seven individual components of the PSQI, subjective CF was found to be
predicted by three components of sleep quality: subjective sleep quality, sleep latency, and sleep
duration.
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Also, of interest within the results was the demonstrated negative relationship between
information processing speed and disease disability. This suggests that scores on the SMDT and
ZVT decrease as disease disability increases. Meaning, that increased disability reduces
information processing speed. The cerebral measure on the EDSS assesses problems with
thinking, memory, and attention, which are some of the constructs involved in information
processing speed. Therefore, it is logical that as the score on the EDSS reflects cognitive
impairment, disease disability would be strongly correlated with information processing speed.
This relationship has been previously demonstrated by Golan et al. (2018).
Disease disability was also significantly positively associated with age, suggesting that
older individuals tended to demonstrate greater disease disability. With MS most individuals will
begin in the Relapsing Remitting stage and progress into the Secondary Progressive stage. Thus,
as the disease course continues the disability will also continue; therefore, it would follow that as
PwMS grow older, and their disease duration increases their disease disability would also
increase. The correlational analysis also revealed that age was significantly positively associated
with information processing speed. In a similar fashion, as the disease progresses, disability
increases, and information processing is slowed. It has also been seen in the literature, that aside
from MS, older individuals have slower processing speeds, and more difficulty with working
memory (Diamond et al., 2000).
The present results also suggest that disease disability is positively correlated with
depression, as measured by the HADS. This relationship agrees with previously published
research, and is likely to reflect decreased quality of life that is caused by increased disease
symptoms (Benedict et al., 2005).
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Information processing speed was found to be significantly associated with depression
when measured by the ZVT, but not when measured by the SDMT. This is interesting as the
SDMT and ZVT are very strongly correlated with one another and show a similar pattern of
correlations within the variables measured in this study. The two main differences between the
measures are physical capabilities (holding and using a pen) and memory, as both tests require
some form of attention and decision making. As working memory and depression are reported to
be strongly correlated (Airaksinen, Larsson, Lundberg, & Forsell, 2004; Christopher &
MacDonald, 2005), it does not follow that this would be the cause of the not significant
relationship between the SDMT and depression. Thus, a possible explanation for the ZVT to be
significant and not the SDMT, is the physical impairment of the participants, as mentioned
above. Specifically, if a participant were struggling with the use of a pen, this may impact on
their ZVT score to a greater extent than a participant who does not have impaired grip strength.
The current study did not collect specific impairment information for analysis, in order to test
this, further research would need to be conducted. While possible, this explanation does not
explain the significant correlation between the SDMT and disease disability. Therefore, the most
likely potential explanation for the difference is that the ZVT was consistently given later in the
test battery (after both the SDMT and the HADS), and participants may be more fatigued when
completing the measure. This would support the greater correlation between subjective CF and
the ZVT than the relationship between the SDMT and subjective CF, as literature suggests that
subjective CF increases during cognitive activity (Bailey et al., 2007; Paul et al., 1998).
Another interesting, but expected, finding is the interaction between depression, anxiety,
and sleep quality. Vitkova et al. (2014) demonstrated that anxiety (as measured by the HADS) is
only significantly associated with sleep quality in the early stages of MS (i.e., less than five years
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from point of onset). Additionally, anxiety (as measured by the State-Trait Anxiety Inventory),
has shown a significant overall association with sleep quality in PwMS (Siengsukon et al., 2018).
The strong correlation between depression and sleep quality has been previously demonstrated
(Berard et al., 2019; Strober & Arnett, 2005). As the seven components of sleep quality revealed
unique relationships with subjective CF, the seven facets were correlated with depression and
anxiety. The correlations revealed the same three components correlated with both depression
and anxiety: subjective sleep quality, sleep disturbances, and daytime dysfunction.
Finally, subjective CF, as measured by the MFIS cognitive subscale, was correlated with
all collected variables. Previous research has found that subjective CF is not significantly
associated with age (Walker et al., 2012), disease disability (Berard et al., 2019), or objective CF
(Bailey et al., 2007; Berard et al., 2019; Bryant et al., 2004; Golan et al., 2018) – and this lack of
relationship was similarly borne out in the present study. It has also been demonstrated in past
research that subjective CF is significantly associated with depression (Berard et al., 2019;
Strober & Arnett, 2005), information processing speed (Bailey et al., 2007; Golan et al., 2018),
and sleep quality (Berard et al., 2019; Strober & Arnett, 2005). Unique to this study is the strong
positive correlation with anxiety.
2.4.2

Limitations
The major limitation of the current study is the small sample size. Convenience sampling

was used to recruit participants for this study, wherein patients were approached and asked if
they would be interested in participating in the current study following their appointments at the
clinic. As such, many interested patients may have chosen not to participate due to fatigue
following their appointment. Therefore, the fatigue caused by the appointment is suggestive of
increased CF which may have resulted in decreased participation. Therefore, it is possible that

47

patients that were less fatigued by the appointment were more amenable to participate in the
study, thus representing a less fatigable sample. Moreover, individuals that are more likely to
agree to participate in research following an appointment are less likely to experience the
variables that were being tested for. For example, the sample only included six non-Relapsing
Remitting PwMS (89% of participants were Relapsing Remitting). Therefore, disease disability
is likely lower than it would be if more participants were in the progressive stage of the disease –
and this may help to explain why disease disability was not predictive of subjective CF, as has
been previously demonstrated (Strober & Arnett, 2005).
Another limitation of the study is the self-report measurements used. It is interesting that
the majority of significant findings in the current research were dependent upon the participants’
perception of self (mood, fatigue, and sleep quality). It would have been interesting to include
objective measurements of sleep quality and mood disorders. In addition to investigating the
relationship between CF and objective mood and sleep quality, it would be beneficial to observe
the relationship between subjective and objective measures of mood and sleep quality. This
could be another direction in which the research could continue.
2.4.3

Future Directions
It is recommended that further research be conducted on objective CF and its potential

relationship with information processing speed and anxiety. Also, as recommended in previous
research (Beiske et al., 2008; Morrison & Stuifbergen, 2016), non-pharmacological treatment for
PwMS experiencing subjective CF should be implemented. As subjective CF is strongly
associated with depression, cognitive therapy could be beneficial. There is currently research
being conducted in regard to mindfulness for PwMS, and if this proves fruitful, further research
into non-pharmacological potential treatment options should be conducted.
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2.4.4

Conclusions
In conclusion, depression and information processing speed are both strongly associated

with subjective CF in PwMS. As depression, anxiety, and slowed information processing speed
are negatively associated with quality of life (Benedict et al., 2005) more research is needed to
continue to learn about the individual mechanisms contributing to depression, anxiety, and
information processing speed in PwMS. The current study has found evidence to support further
research into anxiety and information processing speed, and to determine what is causing
anxiety, depression, and the difference between information processing speed measures.
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Chapter 3
3.1
3.1.1

General Discussion
Relationship Between Subjective and Objective CF
The current study measured subjective cognitive fatigue (CF) using the cognitive subscale

of the Modified Fatigue Impact Scale (MFIS), a common test of perceived fatigue used in
Persons with Multiple Sclerosis (PwMS), and measured objective CF with the Paced Auditory
Serial Addition Test (PASAT), a test of information processing speed, attention, and working
memory, commonly used to assess CF in PwMS. As hypothesized, the current research did not
find a relationship between subjective and objective CF. In previous research, objective and
subjective CF has been significantly associated (Walker, Berard, Berrigan, Rees, & Freedman,
2012), but more commonly not associated with one another (Bailey, Channon, & Beaumont,
2007; Berard, Smith, & Walker, 2019; Golan et al., 2018). The findings of Berard et al. (2019)
have been replicated in the current study as the same measurements were utilized (i.e., PASAT
and MFIS). The PASAT and MFIS have consistently demonstrated objective and subjective CF
in PwMS and therefore are logically the best and most reliable indicators of CF (Berard et al.,
2019; Morrow, Rosehart, & Johnson, 2015; Schwid et al., 2003; Walker et al., 2012). Perhaps
with different measurements a relationship would be seen between subjective and objective CF;
however, this seems unlikely, as other researchers have been unable to find a relationship using
varying methods of measurement, including the Fatigue Impact Scale, the n -Back test, the
Computerized Test of Information Processing, and other measures of cognitive dysfunction
(Bailey et al., 2007; Golan et al., 2018; Paul, Beatty, Schneider, Blanco, & Hames, 1998).
Finally, given the concordance with earlier research, including studies with substantially larger
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sample sizes (e.g., Golan et al., 2018), it is unlikely that the lack of significant relationship is
reflective of power issues within the present study.
3.1.2

Predictors of Objective CF
The current study did not find any significant predictors of objective CF. Previous research

had found sleep quality and depression to be significant predictors of objective CF (Berard et al.,
2019), and it was hypothesized that in addition to sleep quality and depression, anxiety, disease
severity, and information processing speed would also be significant predictors of objective CF.
The current research used the Pittsburgh Sleep Quality Index (PSQI) to assess sleep quality, the
Hospital Anxiety and Depression Scale (HADS) to assess both depression and anxiety, the
Symbol Digit Modalities Test (SDMT) and the Zahlen Verbindungs Test (ZVT) to assess
information processing speed, and the Expanded Disability Status Scale (EDSS) to assess disease
disability. The PSQI and EDSS had been previously analyzed in relation to objective CF, and it
was found that while both were a part of the best fit model, only the PSQI was a uniquely
significant predictor of objective CF in PwMS (Berard et al., 2019). As information processing
speed and anxiety had not been previously analyzed as predictors of objective CF, it was of
interest to see how these variables interacted, if at all, to predict objective CF. Interestingly, our
sample did not yield any significant findings with the PASAT. While there was a difference
observed between the first third and last third of the PASAT for some of the sample, there was
no significant finding of objective CF. This could be a function of small sample size, or
participants having improved performance on the PASAT due to repetitive testing (i.e. practice
effect).
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3.1.3

Predictors of Subjective CF
The regression analysis for subjective CF found that the combination of variables

(depression, anxiety, sleep quality, information processing speed, and disease disability) was
significantly predictive of subjective CF in PwMS. When evaluated together in a direct-entry
regression model, depression and information processing speed (as measured by the SDMT),
uniquely predicted subjective CF. Literature has suggested that depression, sleep quality, and
disease disability are significant predictors of subjective CF, accounting for 43% of the variance
(Strober & Arnett, 2005). Interestingly, sleep quality and disease disability were not found to be
unique significant predictors of subjective CF in the current research. This is most likely due to
the inclusion of anxiety and information processing speed, as they had not been previously
investigated as predictors of subjective CF. The finding that information processing speed and
anxiety predict subjective CF has not been demonstrated in past research.
While research has not previously demonstrated a predictive relationship between
information processing speed and subjective CF, an association between the two has been
demonstrated in the past (Golan et al., 2018). It may be that an individual with a slower
information processing speed may need to engage in additional processing, and may therefore
experience a subjectively greater level of CF.
Depression has been previously demonstrated to be a strong independent predictor of
subjective CF (Morrison & Stuifbergen, 2016; Strober & Arnett, 2005). Past research has also
highlighted the relationship between sleep quality and depression. It has been suggested that poor
sleep quality is a symptom of depression (Morrison & Stuifbergen, 2016), although other
research has suggested that sleep quality is independent of depression, and a result of physical
complaints rather than psychosocial complaints (Strober & Arnett, 2005).
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3.1.4

Sleep Quality
While overall sleep quality was not uniquely predictive of subjective CF, further analysis

revealed that the combination of the seven components is predictive of subjective CF. In
particular three components of sleep quality are unique predictors of subjective CF. As previous
work has demonstrated a relationship between subjective CF and sleep quality (Berard et al.,
2019; Strober & Arnett, 2005), and the current study found a significant relationship between
subjective CF and sleep quality, we were interested in delving into the facets of sleep quality to
learn more about the interaction. This was the first study to examine the independent components
of sleep quality, and their predictiveness of subjective CF. It was found that subjective sleep
quality (what an individual perceives their sleep quality to be), sleep latency (how long it takes
an individual to fall asleep at night), and sleep duration (how long an individual is asleep on
average each night), predict subjective CF in PwMS. This means that individuals who sleep less,
take longer to fall asleep, and perceive poor sleep quality are more likely to experience
subjective CF.
As the link between insomnia and depression is well established (e.g., Baron, Corden, Jin,
& Mohr, 2011), it follows that sleep quality would not be uniquely predictive of subjective CF
when both sleep quality and depression are combined. However, when depression and sleep
quality were correlated, the three dimensions of sleep quality associated with depression were:
subjective sleep quality, sleep disturbances, and daytime dysfunction. This suggests that there is
no significant relationship between depression and sleep latency and duration, key aspects of
insomnia. Daytime dysfunction can be considered a result of the sleep disturbances (e.g. too hot,
pain, and noises), which are characterized in the PSQI as reasons for sleep interruptions. Due to
the relationships observed, it may be that Strober and Arnett (2005) were closest in their
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prediction that sleep quality is a symptom of physical (e.g. pain and temperature) rather than
psychosocial (e.g. depression and anxiety) complaints. From this perspective, our observation
that there is no statistically significant mediation relationship between depression and subjective
CF, is unsurprising.
3.1.5

Mediation Analysis
As information processing speed has been linked with depression in the past (Diamond,

Johnson, Kaufman, & Graves, 2008; Golan et al., 2018; Mackin et al., 2014; Siengsukon et al.,
2018), and both were found to be significantly predictive of subjective CF in the current
research, a mediation analysis was conducted to determine whether or not they are unique
predictors of subjective CF. It was thought that information processing speed was slowed in
PwMS due to the added symptoms of depression, and resulted in an elevated experience of
subjective CF. The results of the mediation analysis did not reveal a mediating effect of
information processing speed between depression and subjective CF. Thus, suggesting that
information processing speed is not a result of depression in PwMS, but an independent predictor
of subjective CF. This finding makes sense in the current sample, as only the ZVT was correlated
with depression, and the SDMT was the unique predictor of subjective CF, not the ZVT. As
information processing speed has not been investigated in this manner previously, further
research into the varying methods of measuring information processing speed should be
examined.
3.2

Implications
The current research concludes that cognitive facets of MS are more closely related to

subjective CF than physical symptoms. Those who experience CF are more likely to have
depression, anxiety and a slower information processing speed than those who do not experience
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CF. This may suggest that individuals with depression and anxiety may feel more cognitively
fatigued than individuals that do not experience depression and anxiety. The overarching finding
of the research is that CF is predicted by slowed information processing speed, depression, and
anxiety. Therefore, it may be that the best method for alleviating feelings of subjective CF would
be improving depression, anxiety, and information processing speed. Within the non-MS
population, it has been demonstrated that treating depression can have a positive impact on
information processing speed (Mackin et al., 2014). As the relationship between CI (i.e.
information processing speed) and mood disorders (i.e. depression and anxiety) has been
consistent between the non-MS population (McDermott & Ebmeier, 2009; Papakostas, 2014;
Sheline et al., 2006) and the MS population (Diamond et al., 2008; Lester, Stepleman, & Hughes,
2007), it is plausible that treating symptoms of depression among individuals with MS, would be
an effective method of improving feelings of cognitive fatigue. Future research would do well to
investigate the impact of psychotherapy on depression, anxiety, and information processing
speed in PwMS.
3.3

Directions for Future Research
The findings of the current research could have a long-lasting impact on treatment options

for PwMS experiencing subjective CF, as they suggest that the treatment of depression may have
a direct impact on the experience of cognitive fatigue in this population. The relationship
between objective and subjective CF remains concerning, however, and future research should
attempt to further elucidate the nature of this relationship. Additionally, the impact of anxiety on
the subjective experience of cognitive fatigue is a worthwhile avenue for future study. Although
the measurement of anxiety and depression with a single scale (the HADS) is convenient, the
confounding impact of method variance on the predictive power of each of these variables

61

suggests that future studies may wish to include additional measures of anxiety, in an effort to
add richness to the measurement model that might be brought to bear in the investigation of CF.
Given that objective and subjective CF demonstrate independent models of prediction, it may
also be interesting to evaluate self-report measures of information processing speed, and their
relationship with the variables measured in the current research. It is possible that depression and
anxiety have an even stronger predictive effect on feelings of cognitive slowness, as compared to
actual cognitive slowing.
Finally, previous research within our research group has typically included cannabis usage
as an exclusion criterion. While this is defensible, from the standpoint that cannabis is known to
have an impact on cognition and mood disorders (Wadsworth, Moss, Simpson, & Smith, 2006),
and also from the standpoint that cannabis usage was likely to be infrequent before it was
legalized in Canada, future research should investigate the impact of cannabis usage in this
population. As cannabis usage increases within Canada (and within this population) it will be
important to understand how this substance interacts with medical treatments of MS, as well as
non-medical treatments (e.g., psychotherapy) – and how these multiple factors impact on
cognitive fatigue.
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